Kjeldsen SE - Search Results

1

Does blood pressure reduction necessarily compromise cardiac function or renal hemodynamics? Effects of the angiotensin-converting enzyme inhibitor quinapril.

Kjeldsen SE, Gupta RK, Krause L, Weder AB, Julius S. Kjeldsen SE, et al. Am Heart J. 1992 May;123(5):1433-8. doi: 10.1016/0002-8703(92)91066-a. Am Heart J. 1992. PMID: 1575171 Free article. Clinical Trial.

2

Hemodynamic effects of quinapril, a novel angiotensin-converting enzyme inhibitor.

Gupta RK, Kjeldsen SE, Krause L, Kneisley J, Posvar E, Weder AB, Julius S. Gupta RK, et al. Among authors: kjeldsen se. Clin Pharmacol Ther. 1990 Jul;48(1):41-9. doi: 10.1038/clpt.1990.116. Clin Pharmacol Ther. 1990. PMID: 2196144 Free article. Clinical Trial.

3

Contrasting effects of epinephrine on forearm hemodynamics and arterial plasma norepinephrine.

Kjeldsen SE, Petrin J, Weder AB, Julius S. Kjeldsen SE, et al. Am J Hypertens. 1993 May;6(5 Pt 1):369-75. doi: 10.1093/ajh/6.5.369. Am J Hypertens. 1993. PMID: 8512661

4

Platelet function during antihypertensive treatment with quinapril, a novel angiotensin converting enzyme inhibitor.

Gupta RK, Kjeldsen SE, Motley E, Weder AB, Zweifler AJ, Julius S. Gupta RK, et al. Among authors: kjeldsen se. J Cardiovasc Pharmacol. 1991 Jan;17(1):13-9. doi: 10.1097/00005344-199101000-00003. J Cardiovasc Pharmacol. 1991. PMID: 1708046 Clinical Trial.

5

Effect of circulating epinephrine on platelet function and hematocrit.

Kjeldsen SE, Weder AB, Egan B, Neubig R, Zweifler AJ, Julius S. Kjeldsen SE, et al. Hypertension. 1995 May;25(5):1096-105. doi: 10.1161/01.hyp.25.5.1096. Hypertension. 1995. PMID: 7737722

6

Evaluation of self-measured home vs. clinic intra-arterial blood pressure.

Kjeldsen SE, Moan A, Petrin J, Weder AB, Zweifler AJ, Julius S. Kjeldsen SE, et al. Blood Press. 1993 Mar;2(1):28-34. doi: 10.3109/08037059309077523. Blood Press. 1993. PMID: 8193727 Free article.

7

Effects of increased arterial epinephrine on insulin, glucose and phosphate.

Kjeldsen SE, Moan A, Petrin J, Weder AB, Julius S. Kjeldsen SE, et al. Blood Press. 1996 Jan;5(1):27-31. doi: 10.3109/08037059609062103. Blood Press. 1996. PMID: 8777469 Free article.

8

Hypertension optimal treatment (HOT) study: home blood pressure in treated hypertensive subjects.

Kjeldsen SE, Hedner T, Jamerson K, Julius S, Haley WE, Zabalgoitia M, Butt AR, Rahman SN, Hansson L. Kjeldsen SE, et al. Hypertension. 1998 Apr;31(4):1014-20. doi: 10.1161/01.hyp.31.4.1014. Hypertension. 1998. PMID: 9535429 Clinical Trial.

9

Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.

Kjeldsen SE, Dahlöf B, Devereux RB, Julius S, de Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H. Kjeldsen SE, et al. Am J Hypertens. 2000 Aug;13(8):899-906. doi: 10.1016/s0895-7061(00)00280-6. Am J Hypertens. 2000. PMID: 10950398 Clinical Trial.

10

Sympathetic nervous system involvement in essential hypertension: increased platelet noradrenaline coincides with decreased beta-adrenoreceptor responsiveness.

Kjeldsen SE, Zweifler AJ, Petrin J, Weder AB, Julius S. Kjeldsen SE, et al. Blood Press. 1994 May;3(3):164-71. doi: 10.3109/08037059409102247. Blood Press. 1994. PMID: 8069404 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

701 results

Search Page

Filters